A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

May 19, 2018

Study Completion Date

May 28, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
BEHAVIORAL

GlycoLeap

"GlycoLeap is a 24-week programme includes the following features:~Interactive Education Lessons: Beginning week 1, the participant will be presented with a diabetes self-management education curriculum. These lessons are divided into 6 phases, and each lesson is fully accessible online from a computer or mobile phone, and takes approximately 10 - 15 minutes to complete.~The Glyco Mobile Application: During the 24 week intervention period, the participant will use the Glyco mobile application that allows them to track their weight (measured on the wireless weighing scale), self-tested glucose readings (measured using the glucometer kit), and log their foods and meals by taking photos using their phone. A health coach will review the participant's data regularly, provide personalised feedback."

Trial Locations (1)

529203

SingHealth Polyclinics - Tampines, Singapore

All Listed Sponsors
collaborator

SingHealth Polyclinics

OTHER

lead

Duke-NUS Graduate Medical School

OTHER

NCT03091517 - A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes | Biotech Hunter | Biotech Hunter